ZA98214B - Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1. - Google Patents
Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1.Info
- Publication number
- ZA98214B ZA98214B ZA9800214A ZA98214A ZA98214B ZA 98214 B ZA98214 B ZA 98214B ZA 9800214 A ZA9800214 A ZA 9800214A ZA 98214 A ZA98214 A ZA 98214A ZA 98214 B ZA98214 B ZA 98214B
- Authority
- ZA
- South Africa
- Prior art keywords
- treatment
- ingestion
- inhalation
- copolymer
- multiple sclerosis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Treatments Of Macromolecular Shaped Articles (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- General Preparation And Processing Of Foods (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL11998997A IL119989A0 (en) | 1997-01-10 | 1997-01-10 | Pharmaceutical compositions for oral treatment of multiple sclerosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA98214B true ZA98214B (en) | 1999-08-11 |
Family
ID=11069682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9800214A ZA98214B (en) | 1997-01-10 | 1998-01-12 | Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1. |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0975351B1 (ru) |
| JP (1) | JP4216342B2 (ru) |
| KR (1) | KR20000070058A (ru) |
| CN (1) | CN100528222C (ru) |
| AT (1) | ATE356608T1 (ru) |
| AU (1) | AU737287B2 (ru) |
| BR (1) | BRPI9807076B8 (ru) |
| CA (1) | CA2277365C (ru) |
| CZ (1) | CZ297983B6 (ru) |
| DE (1) | DE69837324T2 (ru) |
| EA (1) | EA003128B1 (ru) |
| HK (1) | HK1025737A1 (ru) |
| HU (1) | HU226612B1 (ru) |
| IL (2) | IL119989A0 (ru) |
| NZ (1) | NZ336690A (ru) |
| PL (1) | PL193300B1 (ru) |
| SK (1) | SK284029B6 (ru) |
| WO (1) | WO1998030227A1 (ru) |
| ZA (1) | ZA98214B (ru) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7279172B2 (en) | 1998-07-23 | 2007-10-09 | Yeda Research And Development Co., Ltd. | Treatment of autoimmune conditions with copolymer 1 and related copolymers |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2527760T3 (es) | 1998-07-23 | 2015-01-29 | Yeda Research And Development Co., Ltd. | Tratamiento de enfermedad de Crohn con copolímero 1 y polipéptidos |
| JP2003521448A (ja) * | 1998-07-23 | 2003-07-15 | ザ・プレジデント・アンド・フェローズ・オブ・ハーバード・カレッジ | 合成ペプチドおよび自己免疫疾患治療のための使用方法 |
| US6800287B2 (en) | 1998-09-25 | 2004-10-05 | Yeda Research And Development Co., Ltd. | Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| EP1552831B1 (en) * | 1999-06-04 | 2009-01-07 | Vereniging Voor Christelijk Wetenschappelijk Onderwijs | Use of riluzole for treating multiple sclerosis |
| DE60041365D1 (de) * | 1999-06-04 | 2009-02-26 | Vereniging Voor Christelijk Wetenschappelijk Onderwijs | Verwendung von Riluzol zur Behandlung Multipler Sklerose |
| ZA200206457B (en) | 2000-02-18 | 2003-08-13 | Yeda Res & Dev | Oral, nasal and pulmonary dosage formulations of copolymer 1. |
| DE60120648D1 (de) * | 2000-02-18 | 2006-07-27 | Yeda Res & Dev | Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung |
| WO2001093828A1 (en) * | 2000-06-05 | 2001-12-13 | Teva Pharmaceuticals Industries, Ltd. | The use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders |
| US20020077278A1 (en) | 2000-06-05 | 2002-06-20 | Yong V. Wee | Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders |
| WO2002076503A1 (en) | 2000-06-20 | 2002-10-03 | Mayo Foundation For Medical Education And Research | Treatment of central nervous system diseases by antibodies against glatiramer acetate |
| NZ533327A (en) | 2001-12-04 | 2006-11-30 | Teva Pharma | Processes for the measurement of the potency of glatiramer acetate |
| IL163725A0 (en) | 2002-02-25 | 2005-12-18 | Elan Pharm Inc | Administration of agents for the treatment of inflammation |
| MXPA05007823A (es) * | 2003-01-24 | 2005-10-18 | Elan Pharm Inc | Composicion y tratamiento de enfermedades desmielizantes y paralisis por administracion de agentes remielinizantes. |
| HUE028833T2 (en) | 2004-09-09 | 2017-01-30 | Yeda Res & Dev | Polypeptide mixtures, compositions containing them, process for their preparation, and applications |
| DE202010018377U1 (de) | 2009-08-20 | 2016-02-25 | Yeda Research And Development Co., Ltd. | Niedrigfrequente therapie mit glatirameracetat |
| USRE49251E1 (en) | 2010-01-04 | 2022-10-18 | Mapi Pharma Ltd. | Depot systems comprising glatiramer or pharmacologically acceptable salt thereof |
| US8759302B2 (en) | 2010-03-16 | 2014-06-24 | Teva Pharmaceutical Industries, Ltd. | Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis |
| KR20140019296A (ko) | 2010-10-11 | 2014-02-14 | 테바 파마슈티컬 인더스트리즈 리미티드 | 글라티라머 아세테이트에 대한 임상 반응의 예측성 바이오마커로서의 사이토카인 바이오마커 |
| EP2765857A4 (en) | 2011-10-10 | 2015-12-09 | Teva Pharma | SIMPLE NUCLEOTIDE POLYMORPHISMS USEFUL FOR PREDICTING CLINICAL RESPONSE TO GLATIRAMERATE ACETATE |
| US9617596B2 (en) | 2012-10-10 | 2017-04-11 | Teva Pharmaceutical Industries, Ltd. | Biomarkers predictive for clinical response for glatiramer acetate |
| UY35790A (es) | 2013-10-21 | 2015-05-29 | Teva Pharma | Marcadores genéticos que predicen la respuesta al acetato de glatiramer |
| CN105884866B (zh) * | 2015-01-26 | 2021-04-20 | 漳州未名博欣生物医药有限公司 | 格拉替雷的化学合成方法 |
| US9155775B1 (en) | 2015-01-28 | 2015-10-13 | Teva Pharmaceutical Industries, Ltd. | Process for manufacturing glatiramer acetate product |
| CN112649537B (zh) * | 2015-04-28 | 2024-03-29 | 深圳翰宇药业股份有限公司 | 多肽混合物高效液相色谱分析方法 |
| US12097292B2 (en) | 2016-08-28 | 2024-09-24 | Mapi Pharma Ltd. | Process for preparing microparticles containing glatiramer acetate |
| US11167003B2 (en) | 2017-03-26 | 2021-11-09 | Mapi Pharma Ltd. | Methods for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using sustained release glatiramer depot systems |
| EP3645029B1 (en) | 2017-06-26 | 2023-01-18 | Institut Pasteur | Treatments to eliminate hiv reservoirs and reduce viral load |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5800808A (en) * | 1994-05-24 | 1998-09-01 | Veda Research And Development Co., Ltd. | Copolymer-1 improvements in compositions of copolymers |
| US5719296A (en) * | 1995-10-30 | 1998-02-17 | Merck & Co., Inc. | Pseudopeptide lactam inhibitors of peptide binding to MHC class II proteins |
-
1997
- 1997-01-10 IL IL11998997A patent/IL119989A0/xx unknown
-
1998
- 1998-01-12 NZ NZ336690A patent/NZ336690A/en not_active IP Right Cessation
- 1998-01-12 BR BRPI9807076A patent/BRPI9807076B8/pt not_active IP Right Cessation
- 1998-01-12 SK SK931-99A patent/SK284029B6/sk not_active IP Right Cessation
- 1998-01-12 CN CNB988031221A patent/CN100528222C/zh not_active Expired - Lifetime
- 1998-01-12 KR KR1019997006278A patent/KR20000070058A/ko active Search and Examination
- 1998-01-12 ZA ZA9800214A patent/ZA98214B/xx unknown
- 1998-01-12 EA EA199900621A patent/EA003128B1/ru not_active IP Right Cessation
- 1998-01-12 PL PL334566A patent/PL193300B1/pl unknown
- 1998-01-12 JP JP53110898A patent/JP4216342B2/ja not_active Expired - Lifetime
- 1998-01-12 CA CA2277365A patent/CA2277365C/en not_active Expired - Lifetime
- 1998-01-12 DE DE69837324T patent/DE69837324T2/de not_active Expired - Lifetime
- 1998-01-12 EP EP98901745A patent/EP0975351B1/en not_active Expired - Lifetime
- 1998-01-12 HU HU0001917A patent/HU226612B1/hu unknown
- 1998-01-12 AU AU58195/98A patent/AU737287B2/en not_active Expired
- 1998-01-12 AT AT98901745T patent/ATE356608T1/de not_active IP Right Cessation
- 1998-01-12 CZ CZ0243799A patent/CZ297983B6/cs not_active IP Right Cessation
- 1998-01-12 WO PCT/US1998/000375 patent/WO1998030227A1/en active IP Right Grant
-
1999
- 1999-07-06 IL IL130820A patent/IL130820A/en not_active IP Right Cessation
-
2000
- 2000-08-01 HK HK00104810A patent/HK1025737A1/xx not_active IP Right Cessation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7279172B2 (en) | 1998-07-23 | 2007-10-09 | Yeda Research And Development Co., Ltd. | Treatment of autoimmune conditions with copolymer 1 and related copolymers |
Also Published As
| Publication number | Publication date |
|---|---|
| HU226612B1 (en) | 2009-04-28 |
| SK93199A3 (en) | 2000-11-07 |
| BR9807076A (pt) | 2000-05-02 |
| EP0975351A4 (en) | 2002-05-15 |
| HK1025737A1 (en) | 2000-11-24 |
| EP0975351A1 (en) | 2000-02-02 |
| CZ243799A3 (cs) | 2000-06-14 |
| DE69837324D1 (de) | 2007-04-26 |
| PL193300B1 (pl) | 2007-01-31 |
| JP2001511121A (ja) | 2001-08-07 |
| EA003128B1 (ru) | 2003-02-27 |
| SK284029B6 (sk) | 2004-08-03 |
| ATE356608T1 (de) | 2007-04-15 |
| IL130820A (en) | 2007-03-08 |
| CN100528222C (zh) | 2009-08-19 |
| HUP0001917A2 (hu) | 2000-10-28 |
| AU737287B2 (en) | 2001-08-16 |
| CN1249690A (zh) | 2000-04-05 |
| HUP0001917A3 (en) | 2001-12-28 |
| BR9807076B1 (pt) | 2013-10-29 |
| WO1998030227A1 (en) | 1998-07-16 |
| JP4216342B2 (ja) | 2009-01-28 |
| AU5819598A (en) | 1998-08-03 |
| NZ336690A (en) | 2001-05-25 |
| KR20000070058A (ko) | 2000-11-25 |
| EA199900621A1 (ru) | 2000-02-28 |
| DE69837324T2 (de) | 2007-11-29 |
| CA2277365C (en) | 2011-04-12 |
| BRPI9807076B8 (pt) | 2021-05-25 |
| PL334566A1 (en) | 2000-03-13 |
| CA2277365A1 (en) | 1998-07-16 |
| CZ297983B6 (cs) | 2007-05-16 |
| EP0975351B1 (en) | 2007-03-14 |
| IL119989A0 (en) | 1997-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1025737A1 (en) | Treatment of multiple sclerosis through ingestion of copolymer-1 | |
| GB0129260D0 (en) | Pharmaceutical compositions and their uses | |
| BG103793A (en) | COMBINED THERAPY USING BENZOTHIAPINS INHIBITING THE ILEAL BILE ACID TRANSPORT AND HMG Co-A REDUCTASE INHIBITORS | |
| UA39158C2 (ru) | Производные n4-оксикарбонил-5'-дезокси-5-фторцитидина и фармацевтический препарат на их основе | |
| ZA943744B (en) | Therapeutic substituted guanidines | |
| IL108007A (en) | USE OF AN INTERFERON-GAMMA (IFN-gamma) INHIBITOR IN THE PREPARATION OF A MEDICAMENT FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE | |
| NZ503308A (en) | Alpha-ketoamide multicatalytic protease inhibitors | |
| IL141157A0 (en) | Salt form of pantoprazole and pharmaceutical compositions containing the same | |
| WO1996021468A3 (en) | Chemically modified interferon | |
| MXPA02010458A (es) | Peptido modulador del receptor de trombopoyetina. | |
| AU4011300A (en) | Compositions and methods for the treatment of immune related diseases | |
| MXPA94009086A (es) | Guanidinas sustituidas terapeuticas. | |
| BG103632A (en) | Pharmaceutical compositions containing ibuprophene and domperidon for migraine treatment | |
| IL111805A0 (en) | Pharmaceutical compositions comprising dimeticone for the treatment of aphthae | |
| AU6849198A (en) | Neurotrypsin | |
| IL111804A0 (en) | Pharmaceutical compositions comprising dimeticone for the treatment of constipation | |
| EP0714404A4 (en) | ANTI-FLAMMABLE PEPTIDES | |
| GB9015774D0 (en) | Novel treatment | |
| GR1002385B (el) | Καθαρη μορφη στρεπτογραμινων, παρασκευη αυτης και φαρμακευτικες συνθεσεις που την περιεχουν. | |
| DE69929802D1 (en) | Lta4 hydrolase-hemmer | |
| TWI226833B (en) | Pharmaceutical composition for inhibiting bone resorption | |
| MY118194A (en) | Pharmaceutical compositions for use in inhibiting bone resorption |